Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction
The signature holds promise for impacting clinical decision-making, pan-cancer patient stratification, and treatment outcomes in immune checkpoint therapies.
Authors
- Joan Frigola (ORCID: https://orcid.org/0000-0003-1887-2432)
- Kinga Bernatowicz (ORCID: https://orcid.org/0000-0001-9166-1709)
- Raquel Pérez-López (ORCID: https://orcid.org/0000-0002-9176-0130)
- Ramon Amat (ORCID: https://orcid.org/0000-0001-8284-2540)
- Rodrigo Almeida Toledo (ORCID: https://orcid.org/0000-0003-3070-6795)
- Francesco Grussu (ORCID: https://orcid.org/0000-0002-0945-3909)
- Manuel Escobar (ORCID: https://orcid.org/0000-0002-3794-2224)
- Garazi Serna (ORCID: https://orcid.org/0000-0003-2666-0982)
- Marta Ligero (ORCID: https://orcid.org/0000-0001-9824-7316)
- Elena Garralda (ORCID: https://orcid.org/0000-0002-4412-7842)
- Paolo Nucíforo (ORCID: https://orcid.org/0000-0003-1380-0990)
- Enriqueta Felip (ORCID: https://orcid.org/0000-0002-7620-0098)
- Olivia Prior (ORCID: https://orcid.org/0009-0000-4913-6716)
- Christina Zatse
Institutions
- Vall d'Hebron Hospital Universitari (ES)
- Vall d'Hebron Institute of Oncology (ES)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/jitc-2024-009140
- Citations
- 22
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 29.92
Funders
- Prostate Cancer Foundation
- Fundación Fero
- CRIS Cancer Foundation
- Instituto de Salud Carlos III